AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 290 filers reported holding AVANOS MED INC in Q4 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,226,000 | -14.0% | 59,429 | +0.1% | 0.86% | +1.8% |
| Q2 2019 | $2,589,000 | -2.3% | 59,378 | -4.3% | 0.84% | +17.3% |
| Q1 2019 | $2,649,000 | -8.3% | 62,057 | -3.8% | 0.72% | -26.6% |
| Q4 2018 | $2,890,000 | -43.2% | 64,515 | -13.1% | 0.98% | -25.3% |
| Q3 2018 | $5,087,000 | – | 74,258 | – | 1.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |